Quick Answer
Opus Genetics, Inc. reported R&D Expense of $5.48 million for fiscal year 2019.
Opus Genetics, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2019 | $5.48M | -58.2% |
| 2018 | $13.11M | +22.3% |
| 2017 | $10.72M | +6.2% |
| 2016 | $10.09M | -16.9% |
| 2015 | $12.15M | +73.2% |
| 2014 | $7.02M | +115.7% |
| 2013 | $3.25M | -4.1% |
| 2012 | $3.39M | -71.7% |
| 2011 | $11.99M | +204.8% |
| 2010 | $3.93M | +23.9% |
| 2009 | $3.18M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2020 | $149.6K | -86.8% | -35.4% |
| June 30, 2020 | $231.6K | -85.9% | -49.3% |
| March 31, 2020 | $456.8K | -79.6% | -59.6% |
| September 30, 2019 | $1.13M | -60.8% | -31.4% |
| June 30, 2019 | $1.65M | -52.0% | -26.5% |
| March 31, 2019 | $2.24M | -44.8% | -22.4% |
| September 30, 2018 | $2.89M | +9.2% | -15.9% |
| June 30, 2018 | $3.43M | +34.9% | -15.4% |
- Opus Genetics, Inc. showed a decrease of -58.2% in R&D Expense compared to the prior fiscal year.
- Over the 2009–2019 period, Opus Genetics, Inc.’s r&d expense has grown by 72.4% (from $3.18 million to $5.48 million).
- The most recent figure is from Opus Genetics, Inc.’s fiscal year 2019 report (Form 10-K), filed with the SEC on February 21, 2020.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: